Recombinant human C1 inhibitor

C1 esterase inhibitor, recombinant · Pharming Technologies B.V.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Recombinant human C1 inhibitor, covering 2012-08-30 to 2013-04-25. Get the full timeline:

Most recent: Clinical Trial Update: Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema [Phase 2]

See pricing